FR2917427B1 - Inhibiteurs de tace dans le traitement de l'acne - Google Patents

Inhibiteurs de tace dans le traitement de l'acne

Info

Publication number
FR2917427B1
FR2917427B1 FR0755819A FR0755819A FR2917427B1 FR 2917427 B1 FR2917427 B1 FR 2917427B1 FR 0755819 A FR0755819 A FR 0755819A FR 0755819 A FR0755819 A FR 0755819A FR 2917427 B1 FR2917427 B1 FR 2917427B1
Authority
FR
France
Prior art keywords
acne treatment
tace inhibitors
tace
inhibitors
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0755819A
Other languages
English (en)
Other versions
FR2917427A1 (fr
Inventor
Jerome Aubert
Isabelle Carlavan
Johannes Voegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0755819A priority Critical patent/FR2917427B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to JP2010512749A priority patent/JP2010532658A/ja
Priority to CA2690593A priority patent/CA2690593A1/fr
Priority to EP08806020A priority patent/EP2160606A2/fr
Priority to PCT/FR2008/051085 priority patent/WO2009004247A2/fr
Publication of FR2917427A1 publication Critical patent/FR2917427A1/fr
Application granted granted Critical
Publication of FR2917427B1 publication Critical patent/FR2917427B1/fr
Priority to US12/640,029 priority patent/US20100168089A1/en
Priority to JP2013206168A priority patent/JP2014051500A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR0755819A 2007-06-18 2007-06-18 Inhibiteurs de tace dans le traitement de l'acne Expired - Fee Related FR2917427B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0755819A FR2917427B1 (fr) 2007-06-18 2007-06-18 Inhibiteurs de tace dans le traitement de l'acne
CA2690593A CA2690593A1 (fr) 2007-06-18 2008-06-18 Inhibiteurs de tace dans le traitement de l'acne
EP08806020A EP2160606A2 (fr) 2007-06-18 2008-06-18 Inhibiteurs de tace dans le traitement de l'acne
PCT/FR2008/051085 WO2009004247A2 (fr) 2007-06-18 2008-06-18 Inhibiteurs de tace dans le traitement de l'acne
JP2010512749A JP2010532658A (ja) 2007-06-18 2008-06-18 ざ瘡の治療におけるｔａｃｅインヒビター
US12/640,029 US20100168089A1 (en) 2007-06-18 2009-12-17 Utilization of tace inhibitors for the treatment of acne
JP2013206168A JP2014051500A (ja) 2007-06-18 2013-10-01 ざ瘡の治療におけるｔａｃｅインヒビター

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755819A FR2917427B1 (fr) 2007-06-18 2007-06-18 Inhibiteurs de tace dans le traitement de l'acne

Publications (2)

Publication Number Publication Date
FR2917427A1 FR2917427A1 (fr) 2008-12-19
FR2917427B1 true FR2917427B1 (fr) 2009-08-21

Family

ID=38961832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0755819A Expired - Fee Related FR2917427B1 (fr) 2007-06-18 2007-06-18 Inhibiteurs de tace dans le traitement de l'acne

Country Status (6)

Country Link
US (1) US20100168089A1 (fr)
EP (1) EP2160606A2 (fr)
JP (2) JP2010532658A (fr)
CA (1) CA2690593A1 (fr)
FR (1) FR2917427B1 (fr)
WO (1) WO2009004247A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140275108A1 (en) * 2013-03-15 2014-09-18 Galderma Research & Development Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
ES2829637T3 (es) * 2014-12-12 2021-06-01 Dermavant Sciences GmbH 3,5-dihidroxi-4-isopropil-trans-estilbeno para su uso en el tratamiento tópico del acné

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID25639A (id) * 1998-02-19 2000-10-19 American Cyanamid Co Alkil, aril atau heteroarilamida tersubstitusi n-hidroksi-2-(alkil, aril, atau heteroaril sulfanil, sulfinil atau sulfonil)-3 sebagai inhibitor matriks mataloproteinase
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
CA2423733A1 (fr) * 2000-08-31 2003-02-14 Terukage Hirata Nouveaux derives d'acide propenohydroxamique
JP2004107220A (ja) * 2002-09-13 2004-04-08 Mitsubishi Pharma Corp ＴＮＦ−α産生抑制剤
US20050276807A1 (en) * 2004-06-15 2005-12-15 Advanced Biotherapy, Inc. Treatment of acne
US20060286108A1 (en) * 2005-06-16 2006-12-21 Bell Katherine A Topical compositions for the treatment of chronic wounds

Also Published As

Publication number Publication date
US20100168089A1 (en) 2010-07-01
WO2009004247A3 (fr) 2009-04-30
JP2010532658A (ja) 2010-10-14
JP2014051500A (ja) 2014-03-20
WO2009004247A2 (fr) 2009-01-08
EP2160606A2 (fr) 2010-03-10
FR2917427A1 (fr) 2008-12-19
CA2690593A1 (fr) 2009-01-08

Similar Documents

Publication Publication Date Title
BRPI0916125A2 (pt) "dispositivo de tratamento"
FR2912833B1 (fr) Panneau pour le traitement acoustique
DK2066759T3 (da) Udfældede vægtningsmidler til anvendelse i borehulsvæsker
SE0950453L (sv) Säkra finansiella transaktioner
BRPI0905692A2 (pt) "bandagem em forma de ilha"
BRPI0819582A2 (pt) "sistema de tratamento de líquido"
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
DK2144905T3 (da) Terapeutiske midler
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
BRPI0809272A2 (pt) Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro
ITMI20062388A1 (it) Dispositivo per l'allineamento di ruote
HK1139861A1 (en) Pde7 inhibitors for use in the treatment of movement disorders 7(pde7)
FR2899476B1 (fr) Association du mazindol dans le traitement du deficit de l'attention/hyperactivite
DE602007008063D1 (de) Hydraulikspanner
DK2173831T3 (da) Brøndbehandling
BRPI0719514A2 (pt) Preparações líquidas aquosas compreendendo gatifloxacina
FR2934267B1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
BRPI0714318A2 (pt) Utilização de 2-benzoil-imidazopiridinas em terapêutica
FR2903999B1 (fr) Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2917427B1 (fr) Inhibiteurs de tace dans le traitement de l'acne
FR2904003B1 (fr) Modulateurs du transporteur abcd3 dans le traitement de l'acne ou de l'hyperseborrhee
FR2932975B1 (fr) Vis d'osteosynthese
FR2929850B1 (fr) Inhibiteurs de l'enzyme tyrosinage
DE602006019048D1 (de) EDDH enthaltende Entzunderungslösungen
DE602006017118D1 (de) Feuchtigkeitsspendendes mittel

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170228